Treatment Duration of Cholinesterase Inhibitor Formulations in Alzheimer's Disease.
OBJECTIVES To examine treatment duration of oral and transdermal cholinesterase inhibitor formulations in older adults with severe Alzheimer's disease (AD) in routine clinical practice. DESIGN Retrospective population-based cohort study. SETTING AND PARTICIPANTS Linked medical and long-term care insurance claims da...